A civil lawsuit alleging that an Omaha pharmaceutical services company participated in fraud has been resolved through mediation. The terms of the resolution were not disclosed.
The East Texas Medical Center Regional Healthcare System had alleged Pharmaceutical Technologies Inc. and its former chief executive officer, Douglas M. Pick, overcharged the health care system's clients and agreed to pay bribes to a Texas hospital official in exchange for the official's continued business.
A Texas judge dismissed the case earlier this month after the parties came to a resolution.
In a statement, the company said, “Terms of the agreement are confidential, but all disputes have been resolved to the satisfaction of both parties and PTI looks forward to continuing to provide exceptional service to its client-partners.”
Pick is no longer employed with PTI, an attorney for the firm said.
The health care system was seeking reimbursement for what it said was $5.8 million in excess fees charged, which it has repaid to clients of its subsidiary HealthFirst.
The hospital system alleged that from 2004 to 2011, Pick and a HealthFirst official conspired to add a $2.90 fee to the price of each prescription filled, with PTI redirecting at least $1.6 million of the money, 75 cents per prescription, to the official through a company incorporated for that purpose.
Federal authorities in April executed a search warrant at PTI's 14301 FNB Parkway offices. The search was led by the Office of Inspector General of the U.S. Department of Health and Human Services, a federal agency that investigates Medicare and Medicaid fraud and abuse.
A court records search shows no criminal charges have been filed.
Contact the writer: